- GW-1100
- TUG-770
- TAK-875
- GSK1292263
| GW9508FFA1/GPR40 agonist,potent and selective |
Sample solution is provided at 25 µL, 10mM.
Nature.2017 Jan 19;541(7637):417-420.
Nature.2018 Nov;563(7731):407-411.Nature.2018 Jun 13.Nature.2018 Jun 27.Nature.2018 Mar 29;555(7698):673-677.Nature.2017 Sep 7;549(7670):96-100.Nature.2016 Apr 21;532(7599):398-401.
Science.2016 Aug 5;353(6299)594-8Nat Nanotechnol.2017 Dec;12(12):1190-1198.Nature Biotechnology.2017 Jun;35(6):569-576Nat Med.2018 Sep 17.Cell.2018 Dec 21. pii: S0092-8674(18)31561-7.Cell.Available online 25 October 2018.Cell.2018 Sep 27. pii: S0092-8674(18)31183-8.Cell.2018 Jun 28;174(1):172-186.e21.Cell.2018 Feb 22;172(5):1007-1021.e17.Cell.2017 Nov 30;171(6):1284-1300.e21.Cell.2017 Aug 17. pii: S0092-8674(17)30869-3.Cell.2017 Jul 13;170(2):312-323Nat Med.2018 Jan 29.Nat Med.2017 Nov;23(11):1342-1351.Cell.2017 Apr 6;169(2):286-300.Cell.2015 Aug 27;162(5):987-1002.Cell.2015 Feb 12;160(4):729-44.Nature Medicine.2017 Apr;23(4):493-500.Cancer Cell.2018 May 14;33(5):905-921.e5.Cancer Cell.2018 Apr 9;33(4):752-769.e8.Cancer Cell.2018 Mar 12;33(3):401-416.e8.Cancer Cell.2017 Aug 14;32(2):253-267.e5.Nat Methods.2018 Jul;15(7):523-526.Cell Stem Cell.2018 May 3;22(5):769-778.e4.Cell Stem Cell.2017 Nov 20. pii: S1934-5909(17)30375-2.Quality Control & MSDS
- View current batch:
- Purity = 98.65%
- COA (Certificate Of Analysis)
- HPLC
- NMR (Nuclear Magnetic Resonance)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
| Description | GW9508 is a small-molecule agonist of GPR40 and GPR120 with EC50 values of 47 nM and 2.2 µM, respectively. | |||||
| Targets | GPR40 | GPR120 | ||||
| IC50 | 47 nM (EC50) | 2.2 µM (EC50) | ||||
GW9508 Dilution Calculator
calculate
GW9508 Molarity Calculator
calculate
| Cas No. | 885101-89-3 | SDF | Download SDF |
| Synonyms | N/A | ||
| Chemical Name | 3-[4-[(3-phenoxyphenyl)methylamino]phenyl]propanoic acid | ||
| Canonical SMILES | C1=CC=C(C=C1)OC2=CC=CC(=C2)CNC3=CC=C(C=C3)CCC(=O)O | ||
| Formula | C22H21NO3 | M.Wt | 347.41 |
| Solubility | ≥16.05mg/mL in DMSO | Storage | Store at -20°C |
| Physical Appearance | A solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. | ||
GW9508 is a selective agonist of GPR40 and 120 with pEC50 value of 7.32 ± 0.03 and 5.46 ± 0.09, respectively [1].GPR40/120 belongs to G protein-coupled receptors (GPCRs) family and is activated by free fatty acids. Mucosal inflammation induced the overexpression of GPR40, GPR120, and several inflammatory cytokines, with correlations between ileal concentrations of tumor necrosis factor (TNF)-α and GPR expression levels [2] [3].GW9508 is a GPR40/120 agonist and is different from the reported GPR40/120 agonist GW1100. When tested with HEK-293 (human embryonic kidney) cells expressing GPR40 or GRP120, GW9508 treatment increased intracellular Ca2+ concentration via activating GPR40/120 in a dose-dependent manner [1]. In rat pancreaticβ-cells, GW9508 treatment activated KATP channels which inhibited GSIS through agonist of GPR40 and GPR120 [4]. When tested with TNF-α treated rat L cells, administration of GW9508 increased the expression of GLP-2 via activating GPR40 and 120 [2].References: [1].Briscoe, C.P., et al., Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol, 2006. 148(5): p. 619-28.[2].Tsukahara, T., et al., Tumor necrosis factor alpha decreases glucagon-like peptide-2 expression by up-regulating G-protein-coupled receptor 120 in Crohn disease. Am J Pathol, 2015. 185(1): p. 185-96.[3].Habib, A.M., et al., Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells. Diabetologia, 2013. 56(6): p. 1413-6.[4].Zhao, Y.F., et al., GW9508 inhibits insulin secretion by activating ATP-sensitive potassium channels in rat pancreatic beta-cells. J Mol Endocrinol, 2013. 51(1): p. 69-77.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
实验需要请问有没有养THP-1细胞的同仁？能否寄一皿我，我在广州南方医科大学，不胜感激！
激光共聚焦的看活细胞皿哪里买呢
想问下各位大神，本人用皿养的PC-9GR细胞突然有大片飘起，也并没有成团状飘起，求解决方法？
如题~
已经基本养好了贴壁的原代细胞了，准备鉴定了，看到好多都在说细胞爬片的问题，我可以不做爬片直接在皿里操作吗？具体需要注意些什么呢？感谢各位大神
ps：大皿和6孔板里细胞密度、培养条件等等都几乎一样。
我看园子里有人提过类似的问题，但还没人给出答案，希望有经验或有想法的战友帮忙分析分析啊~谢谢！
同学说传代必须是一皿传多皿，一皿传一皿就不算传代~求高手指点~~
传代后5天，依然没有长满，怕影响活力，想传代和冻存，不知这样是否可以？？
做细胞实验快半年了，一直都还挺顺的，这次五一放完假回来，复苏一支HK2，操作都跟以前一样，没想到出了好多问题：
冻存方法：包裹棉花直接-80℃过夜，第二天转移到液氮
冻存时间：1个半月前冻存的细胞，密度保证没问题，冻存前状态也好
复苏方法：液氮取出后37℃水浴，约2分钟溶解，加入6倍体积的完全培养基，800转离心5分钟，弃去上清，1ml完全培养基重悬，转移入培养皿（进口一次性塑料培养大皿），补足完全培养基，培养箱培养
第二天看细胞全都没贴壁，但是也没死，聚集成团装飘着，没有污染。不想重新离心加重机械损伤，就一直试试看的心态放在培养箱里养着了。又重新复苏一支，还是一样的结果，全飘着没贴壁。不死心，就往前面复苏的那一皿里直接加了1ml的血清，相当于18%的血清比例，过了一天去看，这下细胞都贴壁了。没有另外添加血清的那一皿就还是没贴壁。
另外还有一支以前复苏的HK2，也是一样的方法复苏的，那次复苏很好，细胞基本没什么死的，也都贴壁了，养在皿里状态也不错，但是拿来铺板就还是不贴壁，同样的培基（10%血清），铺板就一个不贴，皿里就都可以贴上。
求助各位战友：
1、复苏不贴壁是为什么？
2、增加血清比例能使复苏的细胞贴壁，这样的细胞是不是可以认为状态并不好，以后的培养是不是要一直这么高比例的血清？还是可以培养一段时间逐步减少血清比例？
3、仍然是10%血清，为什么铺板就不贴壁，而皿里的就没事？是不是铺板的时候也要增加血清比例呢？那在板里干预的过程中是不是要一直保持高比例的血清培养？
4、我的冻存及复苏方法是否有错？我觉得我的HK2从形态、生长速度上来说状态应该是不错的，而且我已经更换了全新的培基、血清和双抗，重新配置了完全培养基，不知道为什么会出现这种不贴壁的问题
拜托各位集思广益，细胞实验已经为了这个不贴壁的问题停滞快2周，心急如焚啊，拜托各位！
